Adar1 Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Adar1 Capital Management LLC
CRD #299694
SEC #801-130082
CIK #0001940272
AUM $819.9 M (2025-03-31)
Employees 9 (67% Investors, 0% Brokers)
Phone512-254-3790
Address3503 Wild Cherry Drive
Austin, TX 78738
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
90072054036018002011201620212026
Sector Form 13F Holdings Value ($M)
Keros Therapeutics Inc 71.9
Protagonist Therapeutics Inc 52.4
Zai Lab Ltd 29.7
Abivax Sa 23.5
Roivant Sciences Ltd 21.9
Prothena Corp PLC 20.5
Cytokinetics Inc 19.2
CG Oncology Inc 13.6
Bridgebio Pharma Inc 11.2
Inhibikase Therapeutics Inc 10.0
View All
Holdings by Sector ($M)
70056042028014002022202320242026
Type Form D Funds Date Sold ($M) AUM ($M)
HF Adar1 SPV I LP [2025-03-31] 4.3 49.5
HF Adar1 Partners LP [2024-03-28] 4.3 676.0
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 5 819.9
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 5 819.9
By Discretionary
Discretionary 5 819.9
Non-Discretionary 0 0.0
Total 5 819.9
By Non-United States Persons
Non-United States Persons 319.4
United States Persons 500.6
Total 5 819.9
Form D Directors # Filings # Firms 2011 - 2025
Daniel Schneeberger 3
Adar1 Capital Management LLC 3
Stephen Scipione 1
EDGAR Form CIK 2011 - 2025
13F-HR [0001940272]
3 [0001940272]
4 [0001940272]
SC 13D [0001940272]
SC 13G [0001940272]
Form 13D/13G Filer Form 13D/13G Subject Filed
Adar1 Capital Management LLC Bioage Labs Inc [2025-08-14]
Adar1 Capital Management LLC Prothena Corp Public Ltd Co [2025-08-14]
Adar1 Capital Management LLC Keros Therapeutics Inc [2025-04-11]
Adar1 Capital Management LLC Inhibikase Therapeutics Inc [2025-02-14]
Adar1 Capital Management LLC Kiora Pharmaceuticals Inc [2024-11-14]
Adar1 Capital Management LLC Kala Bio Inc [2024-11-14]
Adar1 Capital Management LLC ZURA Bio Ltd [2024-11-14]
Adar1 Capital Management LLC Perceptive Capital Solutions Corp [2024-11-14]
Adar1 Capital Management LLC Pieris Pharmaceuticals Inc [2024-08-01]
Adar1 Capital Management LLC Acasti Pharma Inc [2024-07-10]
Form 3/4/5 Subject 2011 - 2025
ADAR1 Capital Management GP, LLC
ADAR1 Capital Management, LLC
Schneeberger Daniel
ADAR1 Partners, LP
Keros Therapeutics, Inc.
Palvella Therapeutics Inc
Grace Therapeutics, Inc.
Comparable Firms State AUM ($B)
Fort Baker Capital Management LP
CA 0.8
Crow's Nest Holdings LP
VA 0.8
First Citizens Institutional Asset Management LLC
NY 0.8
Pinnbrook Capital Management LP
NY 0.8
Lykos Global Management LP
CT 0.8
Capeview Capital LLP
0.8
Affinity Asset Advisors LLC
NY 0.8
The Cypress Funds LLC
CA 0.8
Enhalus Capital LP
NY 0.8
BWCP LP
TX 0.8
Terms | Privacy | Guide
tony@aum13f.com